OncoSec

bankruptcy failure company closure biotech reprioritization
Special Reports

Biotech bankruptcies hit 10-year peak in 2023

More biotechs filed for bankruptcy in 2023 than any year since 2010, underscoring a brutal year defined by layoffs, company closures and pipeline reprioritizations.
failure crash no fail rocket cancelled end

OncoSec blindsided as blinded review reveals Keytruda combo flop

Apr 4, 2023 10:45am
layoffs cuts restructuring

OncoSec sheds 45% of staff to fund IL-12 through Keytruda trial

Oct 5, 2022 8:55am